FI103889B1 - Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksi

Info

Publication number
FI103889B1
FI103889B1 FI933756A FI933756A FI103889B1 FI 103889 B1 FI103889 B1 FI 103889B1 FI 933756 A FI933756 A FI 933756A FI 933756 A FI933756 A FI 933756A FI 103889 B1 FI103889 B1 FI 103889B1
Authority
FI
Finland
Prior art keywords
alkyl
nz1z2
alkoxy
phenyl
quinoline
Prior art date
Application number
FI933756A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933756A0 (fi
FI933756A (fi
FI103889B (fi
Inventor
Andre Bachy
Laurent Fraisse
Peter Keane
Etienne Mendes
Jean-Claude Vernieres
Jacques Simiand
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of FI933756A0 publication Critical patent/FI933756A0/fi
Publication of FI933756A publication Critical patent/FI933756A/fi
Priority to FI962714A priority Critical patent/FI103277B/fi
Application granted granted Critical
Publication of FI103889B1 publication Critical patent/FI103889B1/fi
Publication of FI103889B publication Critical patent/FI103889B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Toys (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
FI933756A 1992-08-27 1993-08-26 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo£3,2-c|-kinoliini-karboksyylihappojohdannaisten valmistamiseksi FI103889B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI962714A FI103277B (fi) 1992-08-27 1996-07-01 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo- ja tieno£3,2-c|naf tyridiinijohdannaisten valmistamiseksi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9210329A FR2695126B1 (fr) 1992-08-27 1992-08-27 Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.
FR9210329 1992-08-27

Publications (4)

Publication Number Publication Date
FI933756A0 FI933756A0 (fi) 1993-08-26
FI933756A FI933756A (fi) 1994-02-28
FI103889B1 true FI103889B1 (fi) 1999-10-15
FI103889B FI103889B (fi) 1999-10-15

Family

ID=9433050

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933756A FI103889B (fi) 1992-08-27 1993-08-26 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo£3,2-c|-kinoliini-karboksyylihappojohdannaisten valmistamiseksi

Country Status (17)

Country Link
US (2) US5360799A (de)
EP (1) EP0587473B1 (de)
JP (1) JPH06184145A (de)
KR (1) KR100267802B1 (de)
AT (1) ATE173258T1 (de)
AU (1) AU659027B2 (de)
CA (1) CA2104883A1 (de)
DE (1) DE69322033T2 (de)
DK (1) DK0587473T3 (de)
ES (1) ES2125315T3 (de)
FI (1) FI103889B (de)
FR (1) FR2695126B1 (de)
GR (1) GR3029283T3 (de)
HU (1) HU217623B (de)
MX (1) MX9305181A (de)
NO (1) NO300845B1 (de)
NZ (1) NZ248498A (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003256650A1 (en) * 2002-07-19 2004-02-09 Pharmacia Corporation Substituted thiophene carboxamide compounds for the treatment of inflammation
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
CN103214483B (zh) 2005-12-13 2014-12-17 因塞特公司 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2，3-b]吡啶和吡咯并[2，3-b]嘧啶
CN101679357A (zh) * 2007-05-09 2010-03-24 辉瑞大药厂 取代的杂环衍生物及其组合物和作为抗菌剂的药物用途
WO2008154447A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazolonaphthyridine derivatives
WO2009027393A2 (en) 2007-08-27 2009-03-05 Basf Se Pyrazole compounds for controlling invertebrate pests
JP4719317B2 (ja) * 2008-02-26 2011-07-06 武田薬品工業株式会社 縮合複素環誘導体およびその用途
AU2009295936B2 (en) 2008-09-24 2014-07-17 Basf Se Pyrazole compounds for controlling invertebrate pests
BRPI1012159B1 (pt) 2009-05-22 2022-01-25 Incyte Holdings Corporation Compostos derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase, composições farmacêuticas compreendendo os referidos compostos e usos dos mesmos
DK2432472T3 (da) 2009-05-22 2019-11-18 Incyte Holdings Corp 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octan- eller heptan-nitril som jak-inhibitorer
EP2451804B1 (de) 2009-07-06 2014-04-30 Basf Se Pyridazinverbindungen zur bekämpfung von wirbellosen schädlingen
WO2011009804A2 (en) 2009-07-24 2011-01-27 Basf Se Pyridine derivatives compounds for controlling invertebrate pests
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
KR102283091B1 (ko) 2010-03-10 2021-07-30 인사이트 홀딩스 코포레이션 Ｊａｋ１ 저해제로서의 피페리딘­４­일 아제티딘 유도체
AR083933A1 (es) 2010-11-19 2013-04-10 Incyte Corp Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
CN103797010B (zh) 2011-06-20 2016-02-24 因塞特控股公司 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
US9193733B2 (en) 2012-05-18 2015-11-24 Incyte Holdings Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
SG10201703533VA (en) 2012-11-01 2017-06-29 Incyte Corp Tricyclic fused thiophene derivatives as jak inhibitors
CR20190073A (es) 2012-11-15 2019-04-25 Incyte Holdings Corp FORMAS DE DOSIFICACIÓN DE RUXOLITINIB DE LIBERACIÓN SOTENIDA (Divisional 2015-265)
RS62867B1 (sr) 2013-03-06 2022-02-28 Incyte Holdings Corp Postupci i intermedijeri za dobijanje inhibitora jak
EP3030227B1 (de) 2013-08-07 2020-04-08 Incyte Corporation Dosierungsformen mit anhaltender freisetzung für einen jak1-inhibitor
CA2947418A1 (en) 2014-04-30 2015-11-05 Incyte Corporation Processes of preparing a jak1 inhibitor and new forms thereto
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
JP2018537450A (ja) 2015-11-16 2018-12-20 ファンダシオン パラ ラ インベスティガシオン メディカ アプリカダＦｕｎｄａｃｉｏｎ Ｐａｒａ Ｌａ Ｉｎｖｅｓｔｉｇａｓｉｏｎ Ｍｅｄｉｃａ Ａｐｌｉｃａｄａ Ｄｎａメチルトランスフェラーゼ阻害剤としての新規化合物
JP2021519775A (ja) 2018-03-30 2021-08-12 インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ Ｊａｋ阻害剤を用いる化膿性汗腺炎の治療
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
AU2022367432A1 (en) 2021-10-14 2024-05-02 Incyte Corporation Quinoline compounds as inhibitors of kras
US11897883B1 (en) 2023-09-01 2024-02-13 King Faisal University Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11891377B1 (en) 2023-09-06 2024-02-06 King Faisal University Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11866437B1 (en) 2023-09-15 2024-01-09 King Faisal University 1,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitors
US11952378B1 (en) 2023-12-14 2024-04-09 King Faisal University Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887570A (en) * 1973-09-28 1975-06-03 Squibb & Sons Inc Derivatives of pyrazolo(3,4-b)thieno(2,3-d)pyridine-2-carboxylic acids

Also Published As

Publication number Publication date
NO933051L (no) 1994-02-28
JPH06184145A (ja) 1994-07-05
US5360799A (en) 1994-11-01
GR3029283T3 (en) 1999-05-28
FR2695126A1 (fr) 1994-03-04
DE69322033D1 (de) 1998-12-17
NO933051D0 (no) 1993-08-26
KR100267802B1 (ko) 2000-11-01
CA2104883A1 (fr) 1994-02-28
KR940003958A (ko) 1994-03-14
FR2695126B1 (fr) 1994-11-10
HUT64957A (en) 1994-03-28
FI933756A0 (fi) 1993-08-26
US5468750A (en) 1995-11-21
EP0587473B1 (de) 1998-11-11
HU9302425D0 (en) 1993-11-29
FI933756A (fi) 1994-02-28
NZ248498A (en) 1994-09-27
AU659027B2 (en) 1995-05-04
AU4474793A (en) 1994-03-03
DE69322033T2 (de) 1999-06-17
MX9305181A (es) 1994-06-30
FI103889B (fi) 1999-10-15
EP0587473A1 (de) 1994-03-16
DK0587473T3 (da) 1999-07-26
ATE173258T1 (de) 1998-11-15
HU217623B (hu) 2000-03-28
NO300845B1 (no) 1997-08-04
ES2125315T3 (es) 1999-03-01

Similar Documents

Publication Publication Date Title
FI103889B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksi
DK370682A (da) Fremgangsmaade til fremstilling af carbapenemderivater
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
JPS5531042A (en) 1,8-naphthylidine derivative and its salt
AU4872793A (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them
DK663588D0 (da) Hidtil ukendte forbindelser
DK50793D0 (da) Fremgangsmaade til fremstilling af herbicide o-carboxypyridylimidazolinoner
EP0555479A4 (de)
AU557533B2 (en) Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives
DE3270406D1 (en) Amidines, process for their preparation, pharmaceutical compounds containing them and their use

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: SANOFI